Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04701372 · ClinicalTrials.gov registry record
Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention
A clinical trial of Obsessive - Compulsive Disorder, sponsored by NOCD.
- Completed
- Registry status
- 2,069
- Enrollment target
- 1
- Study location
NCT04701372: Completed study of Obsessive - Compulsive Disorder, sponsored by NOCD.
NCT04701372 is a study of Obsessive - Compulsive Disorder that has completed, run by NOCD. The registered enrollment target is 2,069 participants, roughly in line with the 2,040-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04701372, a study of Obsessive - Compulsive Disorder, has completed, sponsored by NOCD.
- COMPLETED
- Registry status
- 2,069 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.
Primary Outcome
self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes
Conditions Studied
Interventions
- BEHAVIORAL Exposure and response prevention therapy
Study Locations (1)
Illinois
- Nocd, Llc - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,069 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2020-11-08 |
What the finished NCT04701372 record still lists
NCT04701372 is an observational study that tracks outcomes without assigning an intervention. Its 2,069 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,040-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target.
The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Exposure and response prevention therapy is the first listed.
NCT04701372 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04701372 about?
NCT04701372 is a clinical study titled "Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention". This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.
What is the current status of trial NCT04701372?
This trial is currently completed. The enrollment target is 2,069 participants. The study started on 2020-01-01. Estimated completion is 2020-11-08.
What conditions does trial NCT04701372 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.
What interventions are being tested in trial NCT04701372?
The interventions under investigation include: Exposure and response prevention therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04701372?
This trial is sponsored by NOCD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04701372 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04701372's enrollment target sits among peer trials
2,069 3rd of 84 higher than 82 of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
RECRUITING · Phase 1
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00588068 · 2,070 participants
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
- NCT06666192 · 2,067 participants · NA
The Ohio State University (OSU) SCREEN Community Program
- NCT07168993 · 2,063 participants · NA
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- NCT04373564 · 2,076 participants · Phase 4
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI